Vischer advised the Matignon Group on its acquisition of 100% of the shares of Meon Clinic and Meon Center, based in Lucerne and Meggen. The company Headquartered in Paris, aesthetic medicine and surgery specialist Matignon Group
Tags :dx1
Vischer advised MCH Group and Bits & Pretzels in joining forces under the joint venture health.tech events and creating health.tech global summit, an international conference for digital innovations in healthcare. The context Rooted
Walder Wyss and Vischer are amongst the firms involved in Granite Bio’s Series A and Series B financing round. In particular Vischer advised Forbion and Sanofi Ventures on all legal issues related to their
Kellerhals Carrard advised Vaud-based start-up NovaMea and its founder Xile Hu in connection with a 9M USD series A financing round. The context Several international VCs led the capital round in question, with all proceeds
Kellerhals Carrard advised Basel-based CGC Genomics Consults on all legal aspects of their pre-seed financing round. Pursuant to the transaction, the Swiss startup secured approximately EUR 1.7 million. The context Several impact and health-tech investors led
Walder Wyss advised technology company Mercury Systems on the strategic supply agreement between its Swiss subsidiary Mercury Mission Systems International (together Mercury) and Cicor Group. Under the terms of the agreement, Cicor Group will acquire
Walder Wyss advised collana IT Group, a portfolio company of Ufenau Capital Partners, on its acquisition of Option 4.0 and Cloudspirit. The context Option 4.0 is a Microsoft solutions partner in the areas of data & AI
Walder Wyss advised the Sogestran Group on its takeover of Duisburg-based shipping company Reederei Jaegers. The transaction includes the acquisition of 57 vessels. The context Headquartered in Le-Havre, France, the Sogestran Group provides a multitude of
Walder Wyss advised Trilantic Europe, in connection with the acquisition of all shares in Axicom HV from German investment company RCP. Pursuant to the deal, it’s Energy Transition Investments, an investment company of Trilantic
Lenz & Staehelin advised Vivalto Partners on Swiss tax matters in connection with its acquisition of Linnea, an international pharmaceutical manufacturer of botanical ingredients based in Switzerland. The context Headquartered in Paris, Vivalto Partners is
